These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 20412333)

  • 1. Understanding hypertrophic cardiomyopathy: implications of diagnosis for the patient and family.
    Khan H; Guglin M
    Int J Clin Pract; 2010 Nov; 64(12):1699-704. PubMed ID: 20412333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic.
    Arad M; Monserrat L; Haron-Khun S; Seidman JG; Seidman CE; Arbustini E; Glikson M; Freimark D
    Isr Med Assoc J; 2014 Nov; 16(11):707-13. PubMed ID: 25558701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
    Sadoul N; de Chillou C; Aliot E; McKenna WJ
    Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypertrophic cardiomyopathy].
    Friart A
    Rev Med Brux; 1995; 16(4):182-4. PubMed ID: 7481219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy in childhood and adolescence - strategies to prevent sudden death.
    Ostman-Smith I
    Fundam Clin Pharmacol; 2010 Oct; 24(5):637-52. PubMed ID: 20727015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertrophic cardiomyopathy--state of the art in 2007.
    Monteiro S; Costa S; Monteiro P; Gonçalves L; Providência LA
    Rev Port Cardiol; 2008 May; 27(5):625-37. PubMed ID: 18717215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertrophic cardiomyopathy: DNA diagnosis, genetic counselling and the risk of sudden cardiac death].
    Baars HF; Christiaans I; de Nijs PT; Cramer MJ; van Langen IM; Doevendans PA
    Ned Tijdschr Geneeskd; 2010; 154():A698. PubMed ID: 20132578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of hypertrophic cardiomyopathy].
    Cecchi F; Olivotto I
    G Ital Cardiol; 1999 Oct; 29(10):1199-203. PubMed ID: 10546134
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypertrophic cardiomyopathy and athlete's heart: a tale of two entities.
    Martín M; Reguero JJ; Castro MG; Coto E; Hernández E; Carro A; Calvo D; de la Tassa CM
    Eur J Echocardiogr; 2009 Jan; 10(1):151-3. PubMed ID: 18713777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syncope, other risk factors, and the implantable defibrillator for sudden death prevention in hypertrophic cardiomyopathy.
    Cotiga D; Ehlert F; Sherrid M
    Anadolu Kardiyol Derg; 2006 Dec; 6 Suppl 2():55-60. PubMed ID: 17162272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertrophic cardiomyopathy--sports-related aspects of diagnosis, therapy, and sports eligibility.
    Hipp AA; Heitkamp HC; Röcker K; Dickhuth HH
    Int J Sports Med; 2004 Jan; 25(1):20-6. PubMed ID: 14750008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice. Hypertrophic obstructive cardiomyopathy.
    Nishimura RA; Holmes DR
    N Engl J Med; 2004 Mar; 350(13):1320-7. PubMed ID: 15044643
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy: electrocardiographic manifestations and other important considerations for the emergency physician.
    Kelly BS; Mattu A; Brady WJ
    Am J Emerg Med; 2007 Jan; 25(1):72-9. PubMed ID: 17157688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of an implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy].
    Hentati M; Ben Ameur I; Kechida Z; Charfeddine H; Hached L; Grati Z; Kammoun S
    Tunis Med; 2003; 81 Suppl 8():675-9. PubMed ID: 14608758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertrophic cardiomyopathy].
    Scheffold T; Binner P; Erdmann J; Schunkert H;
    Herz; 2005 Sep; 30(6):550-7. PubMed ID: 16170688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systolic heart failure in a patient with hypertrophic obstructive cardiomyopathy: a potentially life-threatening complication.
    Whitten SE
    Crit Care Nurse; 2008 Oct; 28(5):44-52; quiz 53. PubMed ID: 18827086
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prognosis of hypertrophic and dilated cardiomyopathy].
    Ikeda H; Imaizumi T
    Nihon Rinsho; 2000 Jan; 58(1):86-92. PubMed ID: 10885294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic cardiomyopathy: individualized therapy for a heterogeneous disease.
    Sherrid MV; Sirak T
    Minerva Cardioangiol; 2008 Dec; 56(6):671-92. PubMed ID: 19092743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interventional treatment in hypertrophic cardiomyopathy].
    Gietzen FH; Schümmelfeder J; Neuser H; Brunn J; Schumacher B; Kerber S
    Herz; 2005 Mar; 30(2):102-10. PubMed ID: 15875098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.